MTOR and cancer: Mutations in the mTOR gene are rare, and on the interrogation of the Institute for Personalized Cancer Therapy (IPCT) database in MD Anderson Cancer Center, we noted a frequency of 1.35% of 20,150 patients screened (platforms included CMS400, STGAv1, STGA DNA2018, and LBPv1) (Fig. 3).